News
GSK said on Friday the European Medicines Agency had accepted the drugmaker's application to expand the use of its ...
GSK plc (LSE/NYSE: GSK) today announced the launch of the Linked by Lupus: Optimal Care Initiative to help support ...
GSK PLC GSK shares dropped 2.45% to £15.12 Friday, on what proved to be an all-around poor trading session for the stock ...
GSK said on Friday the European Medicines Agency had accepted the drugmaker's application to expand the use of its ...
NHS England now offers the "Trojan horse" therapy, belantamab mafodotin (Blenrep) for patients with multiple myeloma.
GSK (LSE:GSK) announced that the European Medicines Agency accepted its regulatory application to expand the use of its RSV ...
Sage Therapeutics Inc. has found itself a buyer that bested the unsolicited acquisition offer a few months ago from fellow ...
Nagpur: A blood donation and health check-up camp was organised on Saturday at the MIDC Industries Association (MIA) premises ...
GSK RSV vaccine Arexvy accepted for regulatory review by EMA to expand use in adults 18 years, older
London: GSK plc has announced that the European Medicines Agency (EMA) has accepted the company's regulatory application to ...
A “heavy workload” and “limited resources” have left the agency unable to meet a June 17 deadline to approve a therapy ...
GSK has licensed its shigella vaccine candidate to Bharat Biotech. The Big Pharma, which has vowed to help Bharat with trial ...
India also impacted by Shigellosis, a severe form of bacterial diarrhoea that disproportionately affects children under five ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results